PRN Medicines Management

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 16751

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway
Interests: medicines management; patient safety; nursing care
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

PRN stands for ‘pro re nata’ and is defined as authorising nurses to administer medications based on their discretion and by the patients’ requests as unscheduled medication administration alone or in combination with routine/regular prescriptions. It is used for medications prescribed by physicians and administered based on nurses’ judgements of patients’ needs and along with the collaboration of pharmacists. Accordingly, the safety of PRN medication practice depends of the expertise of and collaboration between nurses, physicians and pharmacists. Further, the significance of the patient’s role in the appropriate use of PRN medications should be emphasised.

PRN medicins management has many benefits, but its inappropriate use can lead to overdose and overuse of medications and endangering patient safety. Therefore, there is a need for improvement of current international knowledge and connection of researchers’ valuable practical experiences for the development of the safest model of PRN medicine management in various healthcare settings.

In this Special Issue, the editor welcomes qualitative and quantitative research articles, commentaries, letters to the editor, theoretical and methodological reviews on healthcare professionals’ experiences relating to PRN medicines management consisting of prescription, administration and monitoring adverse drug reactions in short-term and long-term healthcare settings and acute care and emergency departments. The suggestion of innovative and practical strategies for improving the safety of PRN medication practice is emphasised.

Prof. Dr. Mojtaba Vaismoradi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pro re nata
  • PRN
  • Medicine management
  • Patient
  • Nurses
  • Healthcare providers’ collaboration
  • Patient safety
  • Drug-related side effects and adverse reactions
  • Medication safety
  • Medication error

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Other

11 pages, 578 KiB  
Commentary
Ethical Tenets of PRN Medicines Management in Healthcare Settings: A Clinical Perspective
by Mojtaba Vaismoradi, Cathrine Fredriksen Moe, Flores Vizcaya-Moreno and Piret Paal
Pharmacy 2021, 9(4), 174; https://doi.org/10.3390/pharmacy9040174 - 22 Oct 2021
Cited by 1 | Viewed by 4912
Abstract
Prescription and administration of pro re nata (PRN) medications has remained a poorly discussed area of the international literature regarding ethical tenets influencing this type of medication practice. In this commentary, ethical tenets of PRN medicines management from the clinical perspective based on [...] Read more.
Prescription and administration of pro re nata (PRN) medications has remained a poorly discussed area of the international literature regarding ethical tenets influencing this type of medication practice. In this commentary, ethical tenets of PRN medicines management from the clinical perspective based on available international literature and published research have been discussed. Three categories were developed by the authors for summarising review findings as follows: ‘benefiting the patient’, ‘making well-informed decision’, and ‘follow up assessment’ as pre-intervention, through-intervention, and post-intervention aspects, respectively. PRN medicines management is mainly intertwined with the ethical tenets of beneficence, nonmaleficence, dignity, autonomy, justice, informed consent, and error disclosure. It is a dynamic process and needs close collaboration between healthcare professionals especially nurses and patients to prevent unethical practice. Full article
(This article belongs to the Special Issue PRN Medicines Management)
Show Figures

Figure 1

15 pages, 758 KiB  
Discussion
PRN Medicines Optimization and Nurse Education
by Mojtaba Vaismoradi, Sue Jordan, Flores Vizcaya-Moreno, Ingrid Friedl and Manela Glarcher
Pharmacy 2020, 8(4), 201; https://doi.org/10.3390/pharmacy8040201 - 26 Oct 2020
Cited by 14 | Viewed by 10002
Abstract
Medicines management is a high-risk and error prone process in healthcare settings, where nurses play an important role to preserve patient safety. In order to create a safe healthcare environment, nurses should recognize challenges that they face in this process, understand factors leading [...] Read more.
Medicines management is a high-risk and error prone process in healthcare settings, where nurses play an important role to preserve patient safety. In order to create a safe healthcare environment, nurses should recognize challenges that they face in this process, understand factors leading to medication errors, identify errors and systematically address them to prevent their future occurrence. “Pro re nata” (PRN, as needed) medicine administration is a relatively neglected area of medicines management in nursing practice, yet has a high potential for medication errors. Currently, the international literature indicates a lack of knowledge of both the competencies required for PRN medicines management and the optimum educational strategies to prepare students for PRN medicines management. To address this deficiency in the literature, the authors have presented a discussion on nurses’ roles in medication safety and the significance and purpose of PRN medications, and suggest a model for preparing nursing students in safe PRN medicines management. The discussion takes into account patient participation and nurse competencies required to safeguard PRN medication practice, providing a background for further research on how to improve the safety of PRN medicines management in clinical practice. Full article
(This article belongs to the Special Issue PRN Medicines Management)
Show Figures

Figure 1

Back to TopTop